Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cyclooxygenase-2 negatively regulates innate lymphoid cell type 2 differentiation and function during allergic lung inflammation
Hong Li, Matthew L. Edin, Daniel Menendez, J. Alyce Bradbury, Joan P. Graves, Artiom Gruzdev, Gregory S. Whitehead, Maria I. Sifre, Laura M. DeGraff, Darryl C. Zeldin
Hong Li, Matthew L. Edin, Daniel Menendez, J. Alyce Bradbury, Joan P. Graves, Artiom Gruzdev, Gregory S. Whitehead, Maria I. Sifre, Laura M. DeGraff, Darryl C. Zeldin
View: Text | PDF
Research Article Immunology Pulmonology

Cyclooxygenase-2 negatively regulates innate lymphoid cell type 2 differentiation and function during allergic lung inflammation

  • Text
  • PDF
Abstract

Type 2 innate lymphoid cells (ILC2) are a population of lineage-negative cells in the lung, gastrointestinal tract, and skin that have emerged as a significant component of type 2 allergic inflammation. The regulation of cyclooxygenase-2 (COX-2) metabolites is critical to the pathophysiology of many inflammatory disorders, including allergic asthma. While COX-2 regulates Th9 and Th17 cell differentiation and function during allergic lung inflammation, it remains unknown whether COX-2 also regulates ILC2 cell differentiation and function under similar conditions. To address this question, we examined lung ILC2 cells from COX-2+/+ and COX-2–/– mice after ovalbumin-induced (OVA-induced) or Alternaria-induced allergic lung inflammation. ILC2 cells were significantly increased in COX-2–/– lungs compared with COX-2+/+ lungs after OVA exposure in vivo. The increase in ILC2 cells was accompanied by an increase in expression of the cytokines IL-5 and IL-13 and of the transcription factor GATA3. Both genetic disruption and selective inhibition of COX-2 significantly increased ILC2 cell differentiation from isolated common lymphoid progenitor cells (CLP) in vitro. Furthermore, COX-2–derived PGE2 acting via EP2 receptors significantly reduced IL-33 and TSLP expression, and it attenuated ILC2 cell differentiation in vitro and in vivo. Thus, during allergic lung inflammation, COX-2–derived PGE2 signals through the EP2 receptor to negatively regulate lung ILC2 cell differentiation and function.

Authors

Hong Li, Matthew L. Edin, Daniel Menendez, J. Alyce Bradbury, Joan P. Graves, Artiom Gruzdev, Gregory S. Whitehead, Maria I. Sifre, Laura M. DeGraff, Darryl C. Zeldin

×

Figure 6

COX-2 disruption alters ILC2 gene expression profiles during allergic lung inflammation.

Options: View larger image (or click on image) Download as PowerPoint

COX-2 disruption alters ILC2 gene expression profiles during allergic l...
Lung cells were isolated from vehicle and OVA-exposed COX-2+/+ and COX-2–/– mice as shown in Figure 1A. Cells from 3 mice per treatment group were pooled and single-cell RNA-seq was performed. (A) Uniform manifold approximation and projection (UMAP) of 6,955 lymphoid cells identified 18 cell clusters, including ILC2 cells (red, #8). (B) The percentage of lymphoid cells identified as ILC2 cells in allergic COX-2+/+ and COX-2–/– mice is shown. (C) Volcano plot (–Log10 [P value] versus Log2 FC) indicates genes differentially expressed between OVA-exposed COX-2+/+ and COX-2–/– ILC2 cells. (D) Normalized enrichment scores (NES) from GSEA indicate the top 5 pathways significantly increased (orange) or decreased (blue) in OVA-exposed COX-2–/– ILC2 cells versus OVA-exposed COX-2+/+ ILC2 cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts